David Cebrián
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
-
- Quinazolinone synthesis and applications 4
- Synthesis and biological activity 3
- Co-authors
- Sonia Alcalá (2 shared papers)Manuel Hidalgo (1 shared paper)Stephan Huber (1 shared paper)Iker Rodríguez-Arabaolaza (2 shared papers)Elena García (1 shared paper)Juan Carlos Ramírez (2 shared papers)Raúl Torres (2 shared papers)Christopher Heeschen (2 shared papers)
In The Last Decade
David Cebrián
16 papers receiving 622 citations
Peers
Comparison fields: 5 of 83
- Oncology 262
- Aging 13
- Molecular Biology 367
- Cancer Research 72
- Pathology and Forensic Medicine 62
Countries citing papers authored by David Cebrián
This map shows the geographic impact of David Cebrián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cebrián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cebrián more than expected).
Fields of papers citing papers by David Cebrián
This network shows the impact of papers produced by David Cebrián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cebrián. The network helps show where David Cebrián may publish in the future.
Co-authors
The 25 scholars most cited alongside David Cebrián, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 333 | |
| 2 | 2015 | 78 | |
| 3 | 2013 | 52 | |
| 4 | 2012 | 37 | |
| 5 | 2019 | 28 | |
| 6 | 2020 | 18 | |
| 7 | 2012 | 16 | |
| 8 | 2012 | 15 | |
| 9 | 2024 | 13 | |
| 10 | 2021 | 10 | |
| 11 | 2018 | 9 | |
| 12 | 2017 | 9 | |
| 13 | 2017 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2013 | 2 | |
| 16 | 2025 | 1 |
About David Cebrián
David Cebrián is a scholar working on Molecular Biology, Organic Chemistry, Pathology and Forensic Medicine, Genetics and Oncology, having authored 16 papers that have together received 634 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Quinazolinone synthesis and applications (4 papers), Cancer Mechanisms and Therapy (4 papers), Synthesis and biological activity (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Cells and Metastasis (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (262 citations), Aging (13 citations), Molecular Biology (367 citations), Cancer Research (72 citations) and Pathology and Forensic Medicine (62 citations). David Cebrián has collaborated with scholars based in Spain, Norway and Germany. Frequent co-authors include Sonia Alcalá, Manuel Hidalgo, Stephan Huber, Iker Rodríguez-Arabaolaza, Elena García, Juan Carlos Ramírez, Raúl Torres, Christopher Heeschen, Rainer Heuchel and Frank Berger. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cell stem cell, European Journal of Medicinal Chemistry, Molecular Cancer Therapeutics and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.